Iovance Biotherapeutics (IOVA) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.8
-0.69
-0.58
-0.47

Details

Expected EPS
-0.8
Actual EPS
-0.47
Surprise EPS
0.33
Surprise Percent
+41.25%

Description

Iovance Biotherapeutics (IOVA) has reported earnings of -0.47 per share for Q2 2023.

0 Comments

Share your thoughts